Globe Newswire

KUALA LUMPUR, Malaysia, June 07, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), is proud to announce the launch of “Socializer”, a consumer version of military-grade secured messenger platform currently serving a European government and businesses. Socializer aims to protect data privacy and facilitate digital asset storage. This initiative, in collaboration with a Switzerland-based provider,... (continue reading...)

BEIJING, June 07, 2024 (GLOBE NEWSWIRE) -- ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today announced that the Company received a written letter from the Nasdaq Stock Market LLC (“Nasdaq”) dated May 29, 2024, notifying the Company that it no longer meets the minimum bid price requirement set... (continue reading...)

LAS VEGAS, June 07, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company (“Live Ventures” or “Company”), today announced that its Board of Directors approved a new stock repurchase program authorizing the Company to repurchase up to $10 million of the Company’s outstanding shares of common stock. This new repurchase program replaces the previous program that expired on June 1, 2024, and will remain effective until... (continue reading...)

TORONTO, June 07, 2024 (GLOBE NEWSWIRE) -- ARHT Media Inc. ("ARHT" or the "Company") (TSXV: ART), (OTCQB: ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, is pleased to announce that the Company has successfully closed the first tranche of a private placement (the "Private Placement") of 2024 Series B secured subordinated debentures (the "Debentures") for an aggregate principal amount... (continue reading...)

DENVER, June 07, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces the publication of a peer-reviewed article in Nature Scientific Reports that describes the mechanism of action of the Company’s Selective Cytopheretic Device (SCD) in the immunomodulation of excessive inflammation. “... (continue reading...)